Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.11. | Evome Medical Technologies Inc: Evome Medical holders approve all matters at AGSM | 1 | Stockwatch | ||
08.11. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders | 67 | GlobeNewswire (Europe) | SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today announced ?the results from its annual general and special meeting of... ► Artikel lesen | |
EVOME MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
15.08. | Evome Medical Technologies Inc: Evome Medical details low-capex plan for revenue | 1 | Stockwatch | ||
15.08. | Evome Medical Technologies Inc.: Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan | 154 | GlobeNewswire (Europe) | Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical... ► Artikel lesen | |
13.08. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
12.08. | Evome Medical Technologies reports Q2 results | 1 | Seeking Alpha | ||
12.08. | Evome Medical Technologies Inc.: Evome Medical Technologies Reports Second Quarter 2024 Financial Results | 473 | GlobeNewswire (Europe) | Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug.... ► Artikel lesen | |
03.07. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
03.07. | Evome Medical Technologies Inc: Evome hires IR Labs for investor relations | 1 | Stockwatch | ||
03.07. | Evome Medical Technologies Inc.: Evome Medical Technologies Retains irlabs for Investor Relations Services | 1 | GlobeNewswire (USA) | ||
03.07. | Evome Medical Technologies Inc: Evome Medical 504,286 shares for debt | 1 | Stockwatch | ||
17.06. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
14.06. | Evome Medical Technologies Inc: Evome receives conditional OK for shares for services | 1 | Stockwatch | ||
14.06. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Securities Issuances | 1 | GlobeNewswire (USA) | ||
03.06. | Evome Medical Technologies Inc: Evome Medical estimates April, May revenue | 1 | Stockwatch | ||
03.06. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2 | 1 | GlobeNewswire (USA) | ||
01.06. | EVOME MEDICAL TECHNOLOGIES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
30.05. | Evome Medical Technologies Inc: Evome Medical talks Biodex revenue growth | 1 | Stockwatch | ||
30.05. | Evome Medical Technologies Inc.: Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt | 122 | GlobeNewswire (Europe) | NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the "Company" or "Evome") (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue... ► Artikel lesen | |
12.04. | Evome Medical Technologies Inc.: Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled | 123 | GlobeNewswire (Europe) | NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,310 | +1,59 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,800 | +1,36 % | Siemens Healthineers Aktie: Fortschrittliches Denken zahlt sich aus! | Die Siemens Healthineers-Aktie verzeichnete am Handelstag eine erfreuliche Entwicklung mit einem Kursgewinn von 1,5 Prozent auf 49,86 Euro im XETRA-Handel. Im Tagesverlauf erreichte das Papier sein... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,250 | +1,95 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 49 auf 52 Euro angehoben und die Einstufung auf "Buy" belassen. Die Ergebnisse des dritten Quartals seien... ► Artikel lesen | |
GERRESHEIMER | 73,85 | +4,83 % | Gerresheimer, Lanxess, SMA Solar, ThyssenKrupp, TUI, Wacker Chemie u.a. - Aktien-Positionen der Wacker Chemie | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
CARL ZEISS MEDITEC | 55,45 | +1,46 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
ECKERT & ZIEGLER | 39,880 | +7,84 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 55 Euro auf "Buy" belassen. Das Auftragsbuch erscheine vielversprechend... ► Artikel lesen | |
TEMPUS AI | 58,59 | +11,64 % | Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences | ||
GENEDX | 78,64 | +9,18 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
HIMS & HERS HEALTH | 24,240 | -0,37 % | Hims & Hers New Growth Category Is a Huge Surprise | ||
INTUITIVE SURGICAL | 525,50 | -0,15 % | Intuitive Surgical-Aktie erreicht 52-Wochen-Hoch bei 552 US-Dollar | ||
TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 12,045 | -0,45 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
UNITEDHEALTH | 567,10 | 0,00 % | UnitedHealth Group: Neues Allzeithoch voraus! | UnitedHealth Group-Aktien konnten am Mittwoch zulegen und sind zum Redaktionsschluss mit einem Tagesgewinn von 2,93 Prozent der Top-Performer im Dow Jones. Aktuell notiert die Aktie bei 594,57 USD,... ► Artikel lesen |